Trials / Unknown
UnknownNCT00372294
To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin \& Dexamethasone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pyrimethamine-sulfadiazine + prednisolone | Administration of pyrimethamine-sulfadiazine + prednisolone |
| DRUG | Clindamycin+Dexamethasone | Intravitreal injection of Clindamycin+Dexamethasone |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2008-08-01
- Completion
- 2008-11-01
- First posted
- 2006-09-06
- Last updated
- 2008-07-30
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00372294. Inclusion in this directory is not an endorsement.